CCCCN1C(=N)N([C@@H](CN2CCC[C@H]2CN2C(N)=NC[C@@H]2Cc2ccccc2)C(C)C)C[C@H]1Cc1ccccc1
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?